Arixtra and Broken bone - a phase IV clinical study of FDA data

Summary:

Broken bone is reported as a side effect among people who take Arixtra (fondaparinux sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Ondansetron, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Broken bone when taking Arixtra. It is created by eHealthMe based on reports of 9,755 people who have side effects when taking Arixtra from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Broken bone?

Broken bone is found to be associated with 1,299 drugs and 1,495 conditions by eHealthMe. Check the latest studies of Broken bone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 24, 2026

9,755 people reported to have side effects when taking Arixtra.
Among them, 27 people (0.28%) have Broken bone.

Among these 27 people:

How long have people been on Arixtra when they have Broken bone? *

What is the gender of people who have Broken bone when taking Arixtra? *

female: 100 %
male: 0.0 %

What is the age of people who have Broken bone when taking Arixtra? *

What are other drugs people take besides Arixtra? *

What are other side effects people have besides Broken bone? *

Weight Increased: 24 people, 88.89%
Joint Pain: 24 people, 88.89%
Abdominal Pain: 24 people, 88.89%
Urinary Tract Infection: 24 people, 88.89%
Peripheral Swelling: 24 people, 88.89%
Nausea (feeling of having an urge to vomit): 24 people, 88.89%
Fever: 24 people, 88.89%
Fluid Retention (an abnormal accumulation of fluid in the blood): 19 people, 70.37%
Joint Swelling: 19 people, 70.37%
Blood Lactate Dehydrogenase Increased: 18 people, 66.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 59.26%
Primary Myelofibrosis (primary disorder of the bone marrow): 8 people, 29.63%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 8 people, 29.63%
Type 2 Diabetes: 2 people, 7.41%
Pain: 2 people, 7.41%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.41%
Hypokalemia (low potassium): 2 people, 7.41%
High Blood Cholesterol: 2 people, 7.41%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 7.41%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and have Broken bone?

- Check whether Broken bone is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arixtra:

Arixtra (9,830 reports)

Broken bone treatments and more:

Broken bone (35,552 reports)

Browse all side effects of Arixtra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Broken bone:

Broken bone (1,299 drugs)

Browse all the conditions that are associated with Broken bone:

Broken bone (1,495 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium (the active ingredients of Arixtra) and Arixtra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.